Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes
Mans Broekgaarden(Inserm), Michal Heger(Utrecht University)
Cited by 99
Related Papers
Photonanomedicine: a convergence of photodynamic therapy and nanotechnology
|Nanoscale|2016|167
Engineering photodynamics for treatment, priming and imaging
|Nature Reviews Bioengineering|2024|160
Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy
|Oncotarget|2015|64
Development and In Vitro Proof-of-Concept of Interstitially Targeted Zinc- Phthalocyanine Liposomes for Photodynamic Therapy
|Current Medicinal Chemistry|2013|51
Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy
|Molecular Cancer Therapeutics|2020|48